Clinical trial
An Initial Evaluation of the Safety and Performance of the Transcatheter Mitral Intrepid Valve Replacement System in Patients With Severe, Symptomatic Mitral Regurgitation
NCT02322840 is registered in ClinicalTrials.gov with Medtronic Cardiovascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Initial Evaluation of the Safety and Performance of the Transcatheter Mitral Intrepid Valve Replacement System in Patients With Severe, Symptomatic Mitral Regurgitation
- Lead sponsor
- Medtronic Cardiovascular
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- April 30, 2015
- Completion date
- December 31, 2028
- Enrollment
- 128 (actual)
- Sites
- 32
Conditions
As the registry lists them; a condition with its own page is linked.